[ad_1]
Centrus Vitality Corp. (NYSE:LEU) is among the many 20 Greatest Performing Shares in 2025.
On December 24, 2025, TheFly reported that UBS stated Centrus Vitality Corp. (NYSE:LEU)’s launch of centrifuge manufacturing reveals escalating demand for uranium enrichment to take care of the present U.S. reactor fleet and projected electrical energy wants from synthetic intelligence knowledge facilities within the 2030s. The corporate acknowledged that past 2027, a U.S. import prohibition on Russian enrichment volumes is anticipated to place the next precedence on rising home enrichment provide. UBS considers the company to be well-positioned for the long run as a result of long-term nature of its capability build-out, and the agency is more likely to obtain appreciable Division of Vitality funding. UBS retains a $245 worth goal and a impartial score.
Individually, TheFly reported on January 6, 2026, that BofA boosted its worth goal for Centrus Vitality Corp. (NYSE:LEU) from $285 to $340 and stored a Impartial score following the corporate’s designation as one in every of three beneficiaries of $900 million in funding for nuclear gasoline capability from the Division of Vitality. The funds will finance the constructing of recent high-assay low-enriched uranium capability in america. BofA famous that the award fell in need of its earlier mannequin expectation.
Centrus Vitality Corp. (NYSE:LEU) engages in offering nuclear gasoline and providers for the nuclear energy business.
Whereas we acknowledge the potential of LEU as an funding, we consider sure AI shares supply higher upside potential and carry much less draw back danger. Should you’re searching for a particularly undervalued AI inventory that additionally stands to learn considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.
READ NEXT: 10 Excessive-Progress EV Shares to Make investments In and 13 Greatest Automobile Shares to Purchase in 2025.
Disclosure. None
[ad_2]
